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http://dx.doi.org/10.1016/j.stemcr.2016.04.012SUMMARYTreatment with several Wnt/b-catenin signaling pathway regulators can change the cellular reprogramming efficiency; however, the
dynamics and role of endogenousWnt/b-catenin signaling in reprogramming remain largely unanswered. Here we identify the upregu-
lation of WNT2 and subsequent b-catenin nuclear accumulation as key events in reprogramming. Transient nuclear accumulation of
b-catenin occurs early in MEF reprogramming. Wnt2 is strongly expressed in the early stage of reprogramming. Wnt2 knockdown
suppresses the nuclear accumulation of b-catenin and reduces the reprogramming efficiency. WNT2 overexpression promotes b-catenin
nuclear accumulation and enhances the reprogramming efficiency. WNT2 contributes to the promotion of cell proliferation. Experi-
ments with several drugs that control the Wnt pathway also indicate the importance of b-catenin nuclear accumulation in reprogram-
ming. Our findings reveal the role of WNT2/b-catenin signaling in reprogramming.INTRODUCTION
Somatic cells can be reprogrammed to induced pluripotent
stem cells (iPSCs) by ectopic expression of defined tran-
scription factors (OCT3/4, KLF4, SOX2, and c-MYC, here-
after referred to as OKSM) (Takahashi and Yamanaka,
2006). While the changes in gene expressions and epige-
netic modifications during reprogramming have been
well studied (Hussein et al., 2014; Koche et al., 2011;
Koga et al., 2014; Mikkelsen et al., 2008; O’Malley et al.,
2013; Polo et al., 2012), the changes in activities of
signaling pathways have not been extensively studied.
TheWnt signaling pathway controls the pluripotency of
embryonic stem cells (ESCs) (Sato et al., 2004).Wnt ligands
inhibit GSK3 activity, resulting in b-catenin stabilization.
Stabilized b-catenin then translocates into the nucleus
and regulates gene expression. Mouse ESCs secrete Wnt li-
gands, and the autocrine Wnt activity is required for the
maintenance of pluripotency (ten Berge et al., 2011).
Mouse ESCs can even be maintained in the so-called 2i
culture condition, the GSK3 inhibitor plus the MEK inhib-
itor (Ying et al., 2008). While Wnt/b-catenin signaling
activates self-renewal of ESCs, it also plays a critical role
in the initiation of differentiation (Murry and Keller,
2008), suggesting its divergent role in ESCs.
The role of Wnt/b-catenin signaling in reprogramming
has also been investigated. Exogenously introduced
WNT3A enhances fibroblast reprogramming in the
absence of c-Myc (Marson et al., 2008). Knockdown or
knockout of T cell factors or treatments with several drugs
that control the Wnt pathway can change the reprogram-
ming efficiency (Aulicino et al., 2014; Ho et al., 2013; Lluis
et al., 2011; Ross et al., 2014; Zhang et al., 2014). However,834 Stem Cell Reports j Vol. 6 j 834–843 j June 14, 2016 j ª 2016 The Autho
This is an open access article under the CC BY-NC-ND license (http://creativit remains controversial whether endogenous Wnt/b-cate-
nin signaling has a stimulatory or inhibitory effect on
reprogramming. Furthermore, the dynamics and role of
endogenous Wnt ligands or b-catenin in reprogramming
remain largely unanswered.
In this study, we find that transient upregulation of
WNT2 induces b-catenin nuclear accumulation and pro-
motes cellular reprogramming.RESULTS
Nuclear Accumulation of b-Catenin Occurs during
MEF Reprogramming
Wnt/b-catenin signaling and c-MYC could play a partially
redundant functional role in reprogramming (Marson
et al., 2008). Moreover, OKSM-induced reprogramming
produces numerous partially reprogrammed cells (Naka-
gawa et al., 2008; Wernig et al., 2008). Therefore, an OKS
method would be more suitable for tracing successful re-
programming. First, we examined the subcellular localiza-
tion of b-catenin. Mouse embryonic fibroblasts (MEFs)
were infected with retroviruses encoding either three tran-
scription factors (OKS) or mCherry (control) at day 0. In
control samples, b-catenin was faintly detected in the cyto-
plasm, but not at all in the nucleus (Figure 1A). In contrast,
in OKS-introduced cells there appeared a fraction of cells,
which exhibited nuclear accumulation of b-catenin at
day 2 (Figure 1B). Both the number of nuclear b-catenin-
positive cells and the staining intensity of nuclear b-cate-
nin were increased at days 4 and 6. At days 8 and 10,
when iPSC-like colonies began to emerge, b-catenin
became localized at or near the plasma membrane inr(s)
ecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Transient Nuclear Accumulation of b-Catenin Occurs during MEF Reprogramming
(A) Control MEFs, which were infected with a retrovirus encoding mCherry instead of OKS, were stained for b-catenin (green). Hoechst,
blue. Higher-magnification images are shown to the right. Representative of three independent experiments. Scale bars, 200 mm.
(B) OKS-introduced MEFs were stained for b-catenin (green). Hoechst, blue. Higher-magnification images are shown to the right.
Representative of three independent experiments. Scale bars, 200 mm.
(legend continued on next page)
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colonies, not in the nucleus, suggesting that b-cateninmay
function as a scaffolding protein for E-cadherin in the later
stages of reprogramming (Li et al., 2010; Perez-Moreno and
Fuchs, 2006; Samavarchi-Tehrani et al., 2010). Nuclear
accumulation of b-catenin was decreased in the later stages
(Figure 1C), suggesting that Wnt/b-catenin signaling is
transiently activated during MEF reprogramming.
Next, we used 7xTcf-eGFP (7TGP) as a reporter of Wnt/
b-catenin activity (Figure 1D; Fuerer and Nusse, 2010).
MEFs were infected with a lentivirus carrying 7TGP. In
the absence of OKS, cells remained 7TGP negative. In
contrast, about 5% of the OKS-introduced MEFs became
7TGP-positive cells at day 6.Wnt/b-catenin signaling target
genes, Axin2 and CyclinD1, were more highly expressed in
7TGP-positive cells than in 7TGP-negative cells (Figures
S1A and S1B). Previous studies have shown that E-cadherin
(epidermal marker) is upregulated while Thy1 (fibroblast-
associated marker) and Slug (mesenchymal marker) are
downregulated during MEF reprogramming (Li et al.,
2010; Samavarchi-Tehrani et al., 2010; Stadtfeld et al.,
2008). Our results showed that E-cadherin was more highly
expressed in 7TGP-positive cells than in 7TGP-negative
cells, and Thy1 and Slug were more highly expressed in
7TGP-negative cells (Figure S1C), suggesting that 7TGP-
positive cells are in a more advanced state. 7TGP-positive
cells expressed higher levels of OKS factors (Figure S1D).
To investigate whether 7TGP-positive cells become iPSCs,
we sorted OSK-introduced MEFs into 7TGP-positive and
-negative cells and evaluated the reprogramming effi-
ciencies. More alkaline phosphatase (AP)-positive and
NANOG-positive iPSC colonies were generated from
7TGP-positive cells (Figure 1E), suggesting that transient
activation ofWnt/b-catenin signaling represents successful
reprogramming.
Wnt2 Expression Is Transiently Increased during MEF
Reprogramming
By examining our microarray data (Koga et al., 2014), we
found thatWnt2 was specifically upregulated prominently
during reprogramming (Figure S2A). qRT-PCR analysis
showed the transient Wnt2 expression (Figure 2A). The
expression level of Wnt2 was quite low in ESCs. The in-(C) 13 104 cells were plated on the cell-culture chamber at day 3. The
were counted. Data are shown as means ± SEM (n = 3 independent ex
(D and E) MEFs were infected with a lentivirus encoding 7xTcf-eGFP (7T
description of 7TGP and fluorescence-activated cell sorting (FACS) plo
cells are outlined in green. The percentages of 7TGP-positive cells a
dependent experiments). The p value was calculated by Student’s t te
7TGP infected-MEFs were sorted on the basis of the 7TGP expression int
coated plates and incubated for 2 weeks. Representative images of AP
bars, 5 mm. The numbers of NANOG-positive colonies were evaluated by
independent experiments). ***p < 0.001 compared with 7TGP-negati
836 Stem Cell Reports j Vol. 6 j 834–843 j June 14, 2016crease in Wnt2 expression preceded those of E-cadherin
and Nanog. The timing of Wnt2 upregulation is similar to
that of b-catenin nuclear accumulation. It was reported
that WNT2 activates Wnt/b-catenin signaling in several
processes (Fu et al., 2011; Goss et al., 2009; You et al.,
2004). The expression patterns of Axin2 and CyclinD1
were similar to that of Wnt2, suggesting that WNT2
induces Wnt/b-catenin signaling target genes during re-
programming (Figure 2B).
We sorted cells based on the expression level of THY1
(Figure 2C). As previously shown, expression patterns of
E-cadherin, Nanog, and Slug in THY1-negative and -posi-
tive cells suggest that THY1-negative cells are in a more
advanced state (Figure 2D) (Polo et al., 2012). Wnt2 was
expressed in both THY1-positive and -negative cells at
day 4 and are then expressed much more highly in
THY1-positive cells, suggesting that Wnt2 is expressed in
the early stage of reprogramming. Axin2 and CyclinD1
were upregulated in both THY1-postive and -negative
cells in the early stage. At day 6, Axin2 and CyclinD1
show slightly lower expression in THY1-negative cells.
The THY1-negative population at day 6 may contain
both types of cells: the cells with nuclear accumulated
b-catenin and the cells that have gone through the tran-
sient b-catenin nuclear accumulation. The expression of
Wnt/b-catenin target genes may be downregulated imme-
diately after the transient b-catenin nuclear accumulation
is completed.
We investigated the role of OKS in Wnt2 expression.
Ectopic expression of any single factor did not induce
Wnt2 expression (Figure S2B). However, OK, OS, and OKS
resulted in a marked increase inWnt2 expression, suggest-
ing that OCT3/4 may play a major role inWnt2 induction
in cooperation with KLF4 and/or SOX2. We investigated
whetherOCT3/4 binds to theWnt2 promoter region. There
are three potential OCT3/4-binding sites in the upstream
region (5,000 bp) of Wnt2 (Figure S2C; Nishimoto et al.,
2003). Chromatin immunoprecipitation assays showed
that OCT3/4 was likely to bind to at least one site (site A)
(Figure S2D), suggesting that OCT3/4 may directly regulate
the expression of Wnt2. We noted that KLF4-binding mo-
tifs and SOX2-binding motifs exist near site A.cells with b-catenin nuclear accumulation per cell-culture chamber
periments).
GP) together with retroviruses encoding OKS at day 0. (D) Schematic
ts of 7TGP expression at day 6 are shown on the left. 7TGP-positive
re shown on the right. Data are shown as means ± SEM (n = 3 in-
st. ***p < 0.001 compared with control cells. (E) At day 6, OKS and
ensity as in Figure S1A. Sorted cells were plated on new feeder layer-
staining and the numbers of AP-positive colonies are shown. Scale
anti-NANOG staining (right). Data are shown as means ± SEM (n = 4
ve cells (Student’s t test).
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Figure 2. Wnt2 Expression Is Transiently Increased during MEF Reprogramming
(A) qRT-PCR analysis. Each mRNA level was normalized to the GAPDH level, and the value at day 0 was set to 1. Data are shown as means ±
SEM (n = 3 independent experiments).
(B) qRT-PCR analysis. Data are shown as means ± SEM (n = 3 independent experiments).
(legend continued on next page)
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WNT2 Regulates Nuclear Accumulation of b-Catenin
and Promotes MEF Reprogramming
We performed Wnt2 knockdown by using short-hairpin
RNAs (shRNAs) against Wnt2. The Wnt2 expression levels
were markedly reduced by each Wnt2 shRNA (Figure 3A).
The Wnt2 knockdown markedly reduced the number of
nuclear b-catenin-positive cells, the numbers of AP-positive
colonies, the numbers of NANOG-positive iPSC colonies,
total cell numbers, and the percentages of NANOG-positive
cells (Figures 3B–3E), suggesting that WNT2 is required for
both the b-catenin nuclear accumulation and the reprog-
ramming progression.
Next we performed WNT2 overexpression, which
increased the number of nuclear b-catenin-positive cells
as well as the numbers of AP-positive colonies, the numbers
of NANOG-positive iPSC colonies, total cell numbers,
and the percentages of NANOG-positive cells (Figures
3F–3I). These results indicate that WNT2 promotes both
the b-catenin nuclear accumulation and the reprogram-
ming process.
At day 5, the rate of cell proliferation was increased in
OKS-introduced MEFs and was further increased by the
ectopic expression of WNT2 (Figure S3A). In contrast, it
was reduced by Wnt2 knockdown (Figure S3B). The pro-
liferative potential was higher in THY1-negative cells
than in THY1-positive cells, suggesting that cell prolifera-
tion is promoted in the early stage (Figure S3C). Thus,
WNT2 regulates cell proliferation in the early stage of
reprogramming.
Nuclear Accumulation of b-Catenin Is Important for
MEF Reprogramming
OKS-introduced MEFs were treated with several small mol-
ecules that inhibit (IWR-1, XAV939, and IWP-2) or activate
(CHIR99021) the Wnt pathway. IWR-1 and XAV939 pro-
mote AXIN stabilization and thereby decrease b-catenin
levels. IWP-2 is an inhibitor of PORCUPINE, which is
necessary for the secretion of Wnt ligands. CHIR99021 in-
hibits GSK3 and thereby stabilizes b-catenin. The numbers
of nuclear b-catenin-positive cells, AP-positive colonies,
and NANOG-positive colonies were reduced by IWR-1,
XAV939, or IWP-2, and increased by CHIR99021 (Fig-
ure 4A). These effects were more prominent in the early
and middle stages than in the late stage (Figure S4A).
Thus, b-catenin nuclear accumulation in the early stage
of reprogramming may be important for efficient
reprogramming.(C) THY1-positive MEFs were collected 1 day before the OKS introduct
THY1 expression and the percentages of THY1-neagtive and -positive
the indicated day based on the THY1 expression intensity. (Lower) FA
and -positive cells. Data are shown as means ± SEM (n = 3 independe
(D) qRT-PCR analysis. Data are shown as means ± SEM (n = 3 indepen
838 Stem Cell Reports j Vol. 6 j 834–843 j June 14, 2016We then performed rescue experiments. Treatment of
Wnt2-knockdown, OKS-introduced MEFs with CHIR99021,
a b-catenin stabilizer, restored the number of nuclear b-cate-
nin-positive cells, the reprogramming efficiency, and
the rate of cell proliferation (Figures 4B, S4B, and S4C).
Furthermore, treatment of WNT2-overexpressed cells
with a b-catenin destabilizer, IWR-1 or XAV939, redu-
ced the increased reprogramming efficiency (Figure 4C).
These results support our idea that WNT2 promotes re-
programming by inducing b-catenin nuclear accumulation.DISCUSSION
We demonstrated that transient upregulation of WNT2 in-
duces b-catenin nuclear accumulation and promotes
reprogramming.
b-Catenin nuclear accumulation decreased after day 6
while Wnt2 expression still remained high until day 10.
There may be two possibilities to explain this time
difference between Wnt2 downregulation and nuclear
b-catenin diminution. (1) b-Catenin can function as a
scaffolding protein for E-cadherin and the binding of
E-cadherin to b-catenin prevents b-catenin nuclear locali-
zation (Orsulic et al., 1999). It can be speculated that
while WNT2 promotes the stabilization of b-catenin in
the early to middle stage of reprogramming, E-cadherin
binds to b-catenin and prevents b-catenin nuclear locali-
zation in the middle stage of reprogramming (days
8–10). (2) Wnt/b-catenin signaling induces the transcrip-
tion of Axin2, which promotes phosphorylation and
degradation of b-catenin (Behrens et al., 1998; Ikeda
et al., 1998; Jho et al., 2002). During reprogramming
this negative feedback could occur, and thus b-catenin
may be degraded in the middle phase of reprogramming,
although Wnt2 is still expressed.
Our results showed that Wnt2 was upregulated in
the early stage of reprogramming and expressed mainly
in THY1-positive cells. A transition from a THY1-positive
state to a THY1-negative state also occurred in the early
stage. WNT2 may act on THY1-positive cells to change
them to THY1-negative cells. Alternatively, it is possible
that WNT2 secreted from THY1-positive cells supports
the reprogramming of THY1-negative cells. Whether
WNT2 acts on THY1-positive or -negative cells in an auto-
crine or paracrine manner should be examined in future
studies.ion as the starting material (day 1). (Upper left) The FACS plot of
cells at day 1. (Upper right) OKS-introduced MEFs were sorted at
CS plots of THY1 expression and the percentages of THY1-neagtive
nt experiments).
dent experiments).
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WNT2 promotes metastasis in several cancers (Fu et al.,
2011; Jiang et al., 2014; Pu et al., 2009). Epithelial-to-
mesenchymal transition takes place in the initiation of
metastasis. On the other hand, mesenchymal-to-epithelial
transition (MET) occurs in the early stage of fibroblast re-
programming (Li et al., 2010; Samavarchi-Tehrani et al.,
2010). Thus, prolonged activation of WNT2/b-catenin
signaling might result in the inhibition of MET during
reprogramming. In fact, our results showed that the expres-
sion of Axin2 and CyclinD1 remained high in THY1-posi-
tive cells during the middle to late phase. It would be
important that WNT2/b-catenin signaling is ‘‘on’’ in the
early stage and switches to ‘‘off’’ in later stages.
Several studies have investigated the involvement of
Wnt signaling in different stages of reprogramming. How-
ever, their results have been controversial (Aulicino et al.,
2014; Ho et al., 2013; Ross et al., 2014; Zhang et al.,
2014). The reprogramming-inducing systems (retroviral
infection or doxycycline-inducible system; OKSM or OKS)
or donor cell types (fibroblasts or neural stem cells) differ
among these studies. In ESCs, the Wnt/b-catenin signaling
pathway contributes to the maintenance of pluripotency,
and on the contrary plays a critical role in early develop-
ment (Miki et al., 2011), implying the context-dependent
role of Wnt/b-catenin signaling. In cell-fusion-mediated
reprogramming, the level of Wnt/b-catenin signaling
activity is critical for successful reprogramming; very high
or very low activities have an inhibitory effect on reprog-
ramming (Lluis et al., 2008). Therefore, one hypothesis
for the opposite effects of endogenous Wnt/b-catenin
signaling on reprogramming is that different reprogram-
ming systems may cause different Wnt/b-catenin activityFigure 3. WNT2 Promotes b-Catenin Nuclear Accumulation and R
(A–E) MEFs were infected with a lentivirus encodingWnt2 shRNAs (sh-W
retroviruses encoding OKS at day 0. (A) Knockdown efficiency of Wnt2
(n = 4 independent experiments).Wnt2 expression levels at day 4 were
cells (Student’s t test). (B) Cells at day 5 were stained for b-cateni
100 mm. (Right) Numbers of cells with b-catenin nuclear accumulatio
independent experiments). *p < 0.05, ***p < 0.001 compared with
11–14 were stained for AP activity. (Left) Representative images of AP
Data are shown as means ± SEM (n = 3 independent experiments). ***
t test). (D) Numbers of NANOG-positive colonies at days 11–14. Data a
0.001 compared with control shRNA-expressing cells (Student’s t test
and right) FACS plots of NANOG expression and the percentages of N
(n = 3 independent experiments). *p < 0.05, **p < 0.01, ***p < 0.00
(F–I) MEFs were infected with a retrovirus encodingWnt2 together with
for b-catenin. Representative images of b-catenin staining. Scale ba
mulation per cell-culture chamber. Data are shown as means ± SEM (
(G) Cells at days 11–14 were stained for AP activity. (Left) Representat
positive colonies. Data are shown as means ± SEM (n = 3 independent
positive colonies at day 11–14. Data are shown as means ± SEM (n = 3
Total cell numbers at day 12. (Center and right) FACS plots of NANOG ex
Data are shown as means ± SEM (n = 3 independent experiments). *p
840 Stem Cell Reports j Vol. 6 j 834–843 j June 14, 2016levels. The changes in Wnt/b-catenin activity levels in
different reprogramming systems should be investigated
in future studies.EXPERIMENTAL PROCEDURES
Cell-Culture Protocols
MEFs were isolated from E14.5 embryos of ICR mice. MEFs and
HEK293Twere maintained in DMEM containing 10% fetal bovine
serum (FBS). Plat-E cells were maintained in DMEM containing
10% FBS, 1 mg/ml puromycin, and 10 mg/ml blasticidin S. The cells
undergoing reprogramming were cultured in standard mouse ESC
medium containing 15% ES-FBS (Thermo Science) and 1,000U/ml
ESGRO LIF (Millipore). ESCs were cultured and passed on gelatin
coated-dishes in mouse ESC medium with 1,500 U/ml LIF. All
mouse experiments were conducted in accordance with the Regu-
lation on Animal Experimentation at Kyoto University and
approved by the Animal Experimentation Committee of Kyoto
University.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures and four figures and can be found with this article on-
line at http://dx.doi.org/10.1016/j.stemcr.2016.04.012.
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Figure 4. b-Catenin Nuclear Accumulation Is Important for MEF Reprogramming
(A) Treatment with an inhibitor (IWR-1, XAV939, or IWP-2), or an activator (CHIR99021) of the Wnt signaling pathway, or DMSO (control).
(Upper) Representative images of b-catenin staining at day 4. Scale bars, 100 mm. (Lower left) Numbers of cells with b-catenin nuclear
accumulation. (Lower center and right) Numbers of AP-positive and NANOG-positive colonies, respectively. Data are shown as means ± SEM
(n = 3 independent experiments). *p < 0.05, ***p < 0.001 compared with control cells treated with DMSO (Student’s t test).
(legend continued on next page)
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